These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 6331340

  • 21. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
    Wang F, Blaese RM, Zoon KC, Tosato G.
    J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263
    [Abstract] [Full Text] [Related]

  • 22. Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis.
    Band PR, Levine PH, Patwardhan VC, Shnitka TK, Pabst HF.
    Can Med Assoc J; 1973 Jan 20; 108(2):183-6. PubMed ID: 4346314
    [Abstract] [Full Text] [Related]

  • 23. Epstein-barr-virus nuclear antigen.
    Vonka V, Hirsch I.
    Prog Med Virol; 1982 Jan 20; 28():145-79. PubMed ID: 6283600
    [No Abstract] [Full Text] [Related]

  • 24. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB, Moss DJ, Wallace LE, Rowe M, Misko IS, Epstein MA, Pope JH.
    Cancer Res; 1981 Nov 20; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract] [Full Text] [Related]

  • 25. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD, Patel J, Schwab H, Martinez J.
    Cytometry B Clin Cytom; 2003 Sep 20; 55(1):22-8. PubMed ID: 12949956
    [Abstract] [Full Text] [Related]

  • 26. Mechanisms other than polyclonal B cell activation possibly involved in Epstein-Barr virus-induced autoimmunity.
    Garzelli C, Pacciardi A, Basolo F, Falcone G.
    Clin Exp Immunol; 1989 Jun 20; 76(3):412-6. PubMed ID: 2546702
    [Abstract] [Full Text] [Related]

  • 27. Induction of plaque-forming cells in human blood lymphocytes cultured in the presence of antigen and Epstein-Barr virus: a study with normal donors and infectious mononucleosis patients.
    Luzzati AL, Heinzer I, Hengartner H, Schreier MH.
    Clin Exp Immunol; 1979 Mar 20; 35(3):405-12. PubMed ID: 222519
    [Abstract] [Full Text] [Related]

  • 28. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J, Suomalainen HA, Parkkinen E, Lundqvist C, Wada G, Koskimies S.
    Med Biol; 1982 Oct 20; 60(5):255-9. PubMed ID: 6296556
    [Abstract] [Full Text] [Related]

  • 29. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
    Imai S.
    Hokkaido Igaku Zasshi; 1990 Sep 20; 65(5):481-92. PubMed ID: 2172132
    [Abstract] [Full Text] [Related]

  • 30. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G, Dewey F, Klein G, Henle G, Henle W.
    J Natl Cancer Inst; 1970 Nov 20; 45(5):989-95. PubMed ID: 18605425
    [Abstract] [Full Text] [Related]

  • 31. [Diagnostic significance of determining antibodies to antigens of the Epstein-Barr virus in infectious mononucleosis].
    Urazova LN, Podoplekin VD, Odintsova LN, Lepekhin AV.
    Lab Delo; 1989 Nov 20; (5):73-4. PubMed ID: 2473271
    [Abstract] [Full Text] [Related]

  • 32. Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. I. Virus-specific and nonspecific components of the cytotoxic response.
    Wallace LE, Rickinson AB, Rowe M, Moss DJ, Allen DJ, Epstein MA.
    Cell Immunol; 1982 Feb 20; 67(1):129-40. PubMed ID: 6176332
    [No Abstract] [Full Text] [Related]

  • 33. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
    Klein G, Purtilo D.
    Cancer Res; 1981 Nov 20; 41(11 Pt 1):4302-4. PubMed ID: 6272974
    [No Abstract] [Full Text] [Related]

  • 34. T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus.
    Rickinson AB.
    Prog Brain Res; 1983 Nov 20; 59():189-202. PubMed ID: 6320264
    [No Abstract] [Full Text] [Related]

  • 35. [Expression of interleukin 2 receptors in in vivo Epstein-Barr virus transformed B lymphocytes].
    Becker H, Helmke K, Federlin K.
    Immun Infekt; 1988 Feb 20; 16(1):21-2. PubMed ID: 2834287
    [Abstract] [Full Text] [Related]

  • 36. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J.
    Scand J Infect Dis Suppl; 1996 Feb 20; 100():72-82. PubMed ID: 8860357
    [Abstract] [Full Text] [Related]

  • 37. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
    White CA, Cross SM, Kurilla MG, Kerr BM, Schmidt C, Misko IS, Khanna R, Moss DJ.
    Virology; 1996 May 15; 219(2):489-92. PubMed ID: 8638417
    [Abstract] [Full Text] [Related]

  • 38. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
    Sauerbrei A, Sprössig M, Wutzler P, Färber I, Schweizer H, Swoboda R, Wilke J.
    Laryngol Rhinol Otol (Stuttg); 1983 Apr 15; 62(4):170-4. PubMed ID: 6191167
    [Abstract] [Full Text] [Related]

  • 39. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
    Lewin N, Aman P, Akerlund B, Gustavsson E, Carenfelt C, Lejdeborn L, Klein G, Klein E.
    Immunol Lett; 1990 Oct 15; 26(1):59-65. PubMed ID: 2177451
    [Abstract] [Full Text] [Related]

  • 40. The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon.
    Thorley-Lawson DA.
    J Immunol; 1981 Mar 15; 126(3):829-33. PubMed ID: 6161964
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.